Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rhoden EL et al. – Approximately two–thirds of men with TD who begin TTh will experience symptomatic benefit and will complete at least 12 months of treatment. Benefit was noted in a majority by 3 months.

Related Articles

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09    Relevance Score: 95%

Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09    Relevance Score: 94%

Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09    Relevance Score: 93%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09    Relevance Score: 91%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09    Relevance Score: 91%

Today in Endocrinology...keeping you current

New psycho-pedagogic approach to obesity treatment: A 5-year follow-up
Patient Education and Counselling, 12/07/09

Environmental pollutants and the thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/07/09

Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address